The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 05, 2023
Filed:
Dec. 18, 2020
Applicant:
Biohaven Therapeutics Ltd., New Haven, CT (US);
Inventors:
Lynn Resnick, Pittsburgh, PA (US);
George T. Topalov, Pittsburgh, PA (US);
Justin K. Belardi, Pittsburgh, PA (US);
James S. Hale, Pittsburgh, PA (US);
Scott S. Harried, Pittsburgh, PA (US);
Charles A. Flentge, Mars, PA (US);
David A. Mareska, McMurray, PA (US);
Assignee:
Biohaven Therapeutics Ltd., Tortola, VG;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 235/30 (2006.01); C07D 413/04 (2006.01); C07D 401/04 (2006.01); C07D 405/12 (2006.01); C07D 403/04 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 235/30 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 403/04 (2013.01); C07D 405/12 (2013.01); C07D 413/04 (2013.01);
Abstract
Optionally substituted benzoimidazol-1,2-yl amides, such as compounds of Formula 1 or Formula 2, can be used to treat disorders associated with a Kv7 potassium channel activator. Compositions, medicaments, and dosage forms related to the treatment are also disclosed herein.